Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Toll-like receptor 4 genetic variation and advanced prostate cancer risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Feb 2007

Cheng Iona, Plummer Sarah J, Casey Graham, Witte John S

Abstract excerpt

Toll-like receptor 4 (TLR4) is a key innate immunity receptor that initiates an inflammatory response primarily against Gram-negative bacteria. Two recent publications reported that variants in TLR4 were associated with risk of prostate cancer. To further investigate the role of TLR4 in prostate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Case-Control Studies
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Logistic Models

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Toll-Like Receptor 4

Source

Identifiers

PMID: 17301271
DOI: 10.1158/1055-9965.EPI-06-0429

Genes

TLR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17301271-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Toll-like receptor 4 genetic variation and advanced prostate cancer risk.PMID 17301271Read ↗

Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.Semantic proximity Read ↗

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.Semantic proximity Read ↗

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.Semantic proximity Read ↗

Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.Semantic proximity Read ↗

Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.Semantic proximity Read ↗

Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.Semantic proximity Read ↗

Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men.Semantic proximity Read ↗

Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.Semantic proximity Read ↗

The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men.Semantic proximity Read ↗

Toll-like receptor signaling pathway variants and prostate cancer mortality.Semantic proximity Read ↗

Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.